{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-008230","form_type":"8-K","ticker":"SGMT","cik":"0001400118","company_name":"Sagimet Biosciences Inc.","filed_at":"2024-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.058748+00:00","generated_at":"2026-06-06T14:50:31.120385+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sagimet Biosciences prices public offering of 9M shares at $12.50/share, raising $112.5M gross","bullets":["Priced 9,000,000 shares of Series A common stock at $12.50/share; gross proceeds ~$112.5M before expenses.","Underwriters granted 30-day option to purchase up to 1,350,000 additional shares at the offering price.","Net proceeds to fund denifanstat Phase 3 program in NASH, TVB-3567 IND for acne, and general corporate.","Offering closed January 30, 2024; Goldman Sachs, TD Cowen, and Leerink acted as joint book-running managers.","All shares sold by Sagimet; no selling stockholders in the offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-008230","json":"https://secwatch.observer/filing/0001104659-24-008230.json","markdown":"https://secwatch.observer/filing/0001104659-24-008230.md","text":"https://secwatch.observer/filing/0001104659-24-008230.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924008230/0001104659-24-008230-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924008230/tm244525d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T14:50:31.120385+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}